LRRK2 and ovarian carcinoma: In ovarian cancer, an increase of miR-205 levels are related to a reduction of its lncRNA sponge LINC01133. This unbalance results in a reduction of the miR-205 target Leucine-rich repeat kinase 2 (LRRK2) and enhanced proliferatory, migratory and invasive ovarian cancer cell ability74.